Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Protein Kinase B (AKT) DNA Hypermethylation with Maintenance Atypical Antipsychotic Treatment in Patients with Bipolar Disorder
Kyle J. Burghardt, Berhane Seyoum, Sabrina E. Dass, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2018) Vol. 38, Iss. 4, pp. 428-435
Open Access | Times Cited: 20

Showing 20 citing articles:

Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain
Diana Grajales, Vítor Ferreira, Ángela M. Valverde
Cells (2019) Vol. 8, Iss. 11, pp. 1336-1336
Open Access | Times Cited: 136
Drug Response-Related DNA Methylation Changes in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
Jiaqi Zhou, Miao Li, Xueying Wang, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 41
Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets
Vincenzo Micale, Martina Di Bartolomeo, Serena Di Martino, et al.
Pharmacology & Therapeutics (2022) Vol. 241, pp. 108279-108279
Closed Access | Times Cited: 30
Epigenetic insights of olanzapine-induced insulin resistance
David Frond, Alke Rettig, Kyle J. Burghardt
Epigenomics (2025), pp. 1-3
Closed Access
Pharmacoepigenetic Processors: Epigenetic Drugs, Drug Resistance, Toxicoepigenetics, and Nutriepigenetics
Ramón Cacabelos, Juan C. Carril, Ana Sanmartín, et al.
Elsevier eBooks (2019), pp. 191-424
Closed Access | Times Cited: 28
Antipsychotic Medications and DNA Methylation in Schizophrenia and Bipolar Disorder: A Systematic Review
Kyle J. Burghardt, Audrey S. Khoury, Zaher Msallaty, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2020) Vol. 40, Iss. 4, pp. 331-342
Open Access | Times Cited: 25
DNA methylation may partly explain psychotropic drug-induced metabolic side effects: results from a prospective 1-month observational study
Céline Dubath, Eleonora Porcu, Aurélie Delacrétaz, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Metabolic effects of atypical antipsychotics: Molecular targets
María Fonseca, Francisca Carmo, Fátima Martel
Journal of Neuroendocrinology (2023) Vol. 35, Iss. 12
Open Access | Times Cited: 5
Alterations in Skeletal Muscle Insulin Signaling DNA Methylation: A Pilot Randomized Controlled Trial of Olanzapine in Healthy Volunteers
Kyle J. Burghardt, Paul Burghardt, Bradley H. Howlett, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1057-1057
Open Access | Times Cited: 1
Phosphoinositide-3-kinase regulatory subunit 1 gene polymorphisms are associated with schizophrenia and bipolar disorder in the Han Chinese population
Jiao Huang, Zhaoxia Chen, Lulu Zhu, et al.
Metabolic Brain Disease (2020) Vol. 35, Iss. 5, pp. 785-792
Closed Access | Times Cited: 8
Skeletal muscle DNA methylation modifications and psychopharmacologic treatment in bipolar disorder
Kyle J. Burghardt, Bradley H. Howlett, Elani Sanders, et al.
European Neuropsychopharmacology (2019) Vol. 29, Iss. 12, pp. 1365-1373
Open Access | Times Cited: 7
Atypical Antipsychotics and the Human Skeletal Muscle Lipidome
Kyle J. Burghardt, Kristen M. Ward, Elani Sanders, et al.
Metabolites (2018) Vol. 8, Iss. 4, pp. 64-64
Open Access | Times Cited: 5
Molecular mechanisms of antipsychotics – their influence on intracellular signaling pathways, and epigenetic and post-transcription processes
Paulina Rok-Bujko
Postępy Psychiatrii i Neurologii (2022) Vol. 31, Iss. 2, pp. 74-84
Open Access | Times Cited: 3
The epigenetic mechanism of metabolic risk in bipolar disorder
Kexin Huang, Sujuan Li, Min Yang, et al.
Obesity Reviews (2024) Vol. 25, Iss. 11
Closed Access
Metabolic Side Effects from Antipsychotic Treatment with Clozapine Linked to Aryl Hydrocarbon Receptor (AhR) Activation
Karin Fehsel
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2294-2294
Open Access
Genetic and Metabolite Variability in One-Carbon Metabolism Applied to an Insulin Resistance Model in Patients With Schizophrenia Receiving Atypical Antipsychotics
Kristen M. Ward, Kyle J. Burghardt, A. Zarina Kraal, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 3
Profiling the Skeletal Muscle Proteome in Patients on Atypical Antipsychotics and Mood Stabilizers
Kyle J. Burghardt, Griffin Calme, Michael Caruso, et al.
Brain Sciences (2022) Vol. 12, Iss. 2, pp. 259-259
Open Access | Times Cited: 1
Epigenetic mechanisms of bipolar disorder
Camila Nayane de Carvalho Lima, Omar Pink, Gabriel R. Fries
Elsevier eBooks (2020), pp. 207-221
Closed Access
DNA methylation in bipolar disorder
Bradley H. Howlett, Marissa A. Kassa, Kyle J. Burghardt
Elsevier eBooks (2022), pp. 267-291
Closed Access
Epigenetics of bipolar disorder
Camila N. C. Lima, Erika M. Salarda, Omar F. Pinjari, et al.
Elsevier eBooks (2021), pp. 335-360
Closed Access
Page 1

Scroll to top